Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients

Tekijä Maughan, A., Sadigh, K., Angulo-Diaz, V., Mandimika, C., Villanueva, M., Lim, J. K., Ogbuagu, O.
Julkaisussa BMC Infect Dis (2019)

Caught in the Act: In Vivo Development of Macrolide Resistance to Campylobacter jejuni Infection

Tekijä Lindow, J. C., Poly, F., Tribble, D. R., Guerry, P., Carmolli, M. P., Baqar, S., Porter, C. K., Pierce, K. K., Darsley, M. J., Sadigh, K. S., Dill, E. A., Kirkpatrick, B. D.
Julkaistu 2010